de Jong IJ - Search Results

1

Preclinical evaluation of a novel ¹¹¹In-labeled bombesin homodimer for improved imaging of GRPR-positive prostate cancer.

Carlucci G, Ananias HJ, Yu Z, Hoving HD, Helfrich W, Dierckx RA, Liu S, de Jong IJ, Elsinga PH. Carlucci G, et al. Among authors: de jong ij. Mol Pharm. 2013 May 6;10(5):1716-24. doi: 10.1021/mp3005462. Epub 2013 Apr 16. Mol Pharm. 2013. PMID: 23590837

2

Visualization of prostate cancer with 11C-choline positron emission tomography.

de Jong IJ, Pruim J, Elsinga PH, Vaalburg W, Mensink HJ. de Jong IJ, et al. Eur Urol. 2002 Jul;42(1):18-23. doi: 10.1016/s0302-2838(02)00129-x. Eur Urol. 2002. PMID: 12121724

3

Visualisation of bladder cancer using (11)C-choline PET: first clinical experience.

de Jong IJ, Pruim J, Elsinga PH, Jongen MM, Mensink HJ, Vaalburg W. de Jong IJ, et al. Eur J Nucl Med Mol Imaging. 2002 Oct;29(10):1283-8. doi: 10.1007/s00259-002-0881-7. Epub 2002 Jul 27. Eur J Nucl Med Mol Imaging. 2002. PMID: 12271408 Clinical Trial.

4

Preoperative staging of pelvic lymph nodes in prostate cancer by 11C-choline PET.

de Jong IJ, Pruim J, Elsinga PH, Vaalburg W, Mensink HJ. de Jong IJ, et al. J Nucl Med. 2003 Mar;44(3):331-5. J Nucl Med. 2003. PMID: 12620996 Free article.

5

11C-choline positron emission tomography for the evaluation after treatment of localized prostate cancer.

de Jong IJ, Pruim J, Elsinga PH, Vaalburg W, Mensink HJ. de Jong IJ, et al. Eur Urol. 2003 Jul;44(1):32-8; discussion 38-9. doi: 10.1016/s0302-2838(03)00207-0. Eur Urol. 2003. PMID: 12814672 Clinical Trial.

6

In vivo uptake of [11C]choline does not correlate with cell proliferation in human prostate cancer.

Breeuwsma AJ, Pruim J, Jongen MM, Suurmeijer AJ, Vaalburg W, Nijman RJ, de Jong IJ. Breeuwsma AJ, et al. Among authors: de jong ij. Eur J Nucl Med Mol Imaging. 2005 Jun;32(6):668-73. doi: 10.1007/s00259-004-1741-4. Epub 2005 Mar 12. Eur J Nucl Med Mol Imaging. 2005. PMID: 15765234 Clinical Trial.

7

Nuclear imaging of prostate cancer with gastrin-releasing-peptide-receptor targeted radiopharmaceuticals.

Ananias HJ, de Jong IJ, Dierckx RA, van de Wiele C, Helfrich W, Elsinga PH. Ananias HJ, et al. Among authors: de jong ij. Curr Pharm Des. 2008;14(28):3033-47. doi: 10.2174/138161208786404335. Curr Pharm Des. 2008. PMID: 18991717 Review.

8

Expression of the gastrin-releasing peptide receptor, the prostate stem cell antigen and the prostate-specific membrane antigen in lymph node and bone metastases of prostate cancer.

Ananias HJ, van den Heuvel MC, Helfrich W, de Jong IJ. Ananias HJ, et al. Among authors: de jong ij. Prostate. 2009 Jul 1;69(10):1101-8. doi: 10.1002/pros.20957. Prostate. 2009. PMID: 19343734

9

Detection of local, regional, and distant recurrence in patients with psa relapse after external-beam radiotherapy using (11)C-choline positron emission tomography.

Breeuwsma AJ, Pruim J, van den Bergh AC, Leliveld AM, Nijman RJ, Dierckx RA, de Jong IJ. Breeuwsma AJ, et al. Among authors: de jong ij. Int J Radiat Oncol Biol Phys. 2010 May 1;77(1):160-4. doi: 10.1016/j.ijrobp.2009.04.090. Epub 2009 Sep 23. Int J Radiat Oncol Biol Phys. 2010. PMID: 19783375

10

PET/CT and radiotherapy in prostate cancer.

De Jong IJ, De Haan TD, Wiegman EM, Van Den Bergh AC, Pruim J, Breeuwsma AJ. De Jong IJ, et al. Among authors: de haan td. Q J Nucl Med Mol Imaging. 2010 Oct;54(5):543-52. Q J Nucl Med Mol Imaging. 2010. PMID: 20927021 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

119 results

Search Page

Filters